Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Docetaxel, Oxaliplatin and S-1 in Gastric Cancer
NCT00816543Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2008
- Primary completion
- May 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, oxaliplatin, tegafur in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Sanofi. Started Dec 2008; status: completed.
02
Drugs
docetaxeloxaliplatintegafur
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00816543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00816543.